HARVARD BIOSCIENCE, INC. Share-based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable
HARVARD BIOSCIENCE, INC. (HBIO) had Share-based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable of 1.04 million shares as of 2022-12-31, per its 10-K filed 2023-03-09.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Payment Arrangement, Option, Exercise Price Range, Beginning of Period
us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions · last filed 2023-03-09
- 2022-12-31: Share-based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable 1.04M shares.
- 2021-12-31: Share-based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable 851.34K shares.
- 2020-12-31: Share-based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable 1.61M shares.
- 2019-12-31: Share-based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable 1.65M shares.
| Period end | Share-based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable |
|---|---|
| 2022-12-31 | 1.04M shares 10-K · filed 2023-03-09 |
| 2021-12-31 | 851.34K shares 10-K · filed 2022-03-11 |
| 2020-12-31 | 1.61M shares 10-K/A · filed 2021-03-17 |
| 2019-12-31 | 1.65M shares 10-K · filed 2020-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |